Gilead Financial News

24.07 / 13:41

Provident FIVE Digital Manufacturing Platform Software Gilead Deal Cognizant extends partnership with biopharma firm Gilead, estimated deal size at $800 million

biopharmaceutical company Gilead Sciences for an additional five years, including renewal and expansion of Cognizant's services, for a total expected value of $800 million. Under the agreement, the NASDAQ-listed IT firm will manage Gilead’s global IT infrastructure, platforms, applications and advanced analytics, and lead initiatives to accelerate its digital transformation.

04.10 / 15:05

Stocks market Tesla UBS Gilead Stocks making the biggest moves premarket: Rivian, Credit Suisse, Poshmark and more

In this article

12.09 / 19:41

Twitter Amgen Gilead Stocks making the biggest moves midday: Bristol-Myers Squibb, Twitter, Gilead Sciences and more

In this article

15.08 / 20:07

Disney Moderna Gilead Stocks making the biggest moves midday: Disney, Poshmark, Vroom and more

In this article

03.08 / 20:19

Booking Moderna CVS Gilead Stocks making the biggest moves midday: Gilead Sciences, CVS, Electronic Arts and more

In this article

28.02 / 21:05

BLOCK Tesla Gilead Stocks making the biggest moves midday: Raytheon, Block, Tesla, Foot Locker and more

In this article

what you should know about Gilead

What is Gilead and why is it gaining attention?

Gilead is a trending topic that interests a wide audience. On our site, we regularly publish updates related to this subject.

Where can I find the latest updates on Gilead?

All new posts about Gilead can be found in the dedicated section. We publish information as it becomes available.

How can I verify the accuracy of information on Gilead?

We rely on trusted sources to ensure that the information about Gilead is reliable and valuable for our readers.